Don Sorensen, President of Big Blue Robot, Offers Pharmaceutical Online Reputation Management Advice

Salt Lake City, Utah (PRWEB) February 21, 2013

Don Sorensen, online reputation management expert and president of Big Blue Robot LLC, today released an article advising Pharmaceutical companies on how to improve their online reputation. The article addresses how Pharmaceutical companies can take proactive steps to improve their online reputation.

Many companies today view online reputation management as a reactive job of monitoring social media and product reviews and then responding to them to make certain customers know that they care. However, there is a growing trend in the pharmaceutical industry of proactive online reputation management efforts and companies are seeing significant benefits.

The reputation of a pharmaceutical company is a precarious thing, says Sorensen. Any negative press about the company or a new medicine can spread like wildfire online, so its imperative to make the most of all the positive content you do have. It is also important to proactively protect not only the corporate reputation, but that of each drug they represent.

Sorensen points out that because bad news can spread so quickly online, reputation management for drug companies depends on maximizing all the positive content available.

Positive content is anything a company wants to show up on the first page of a search, such as an announcement about a new medicine or promising trial results. Maximizing that content so that it is more likely to show up on the first page of a search is a two-step cycle you can repeat endlessly: gather positive content (existing and new), and publicize it.

Gathering Positive Content

Sorensen suggest companies first gather all the positive content the company has about the corporation as a whole and about each drug the company offers. Positive content could include but is not limited to:

This entry was posted in Search Engine Results Page and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply